TABLE 1.
Surgical Patient and Procedure Characteristics by Age Group
| Variable/Age group | Infant to Preschool-Aged, 0–4 y, n = 40 541 (32.6%) | School-Aged Children, 5–10 y, n = 40 221 (32.4%) | Adolescents, 11–17 y,n = 43 487 (35.0%) | Overall, n = 124 249 |
|---|---|---|---|---|
| Patient characteristics | ||||
| Age, median (IQR) | 3.0 (1.0–4.0) | 7.0 (5.0–8.0) | 15.0 (13.0–16.0) | 7.0 (4.0–14.0) |
| Female sex, n (%) | 15 345 (38.0) | 18 191 (45.5) | 22 124 (50.9) | 55 880 (45.0) |
| Surgical procedures, n (%) | ||||
| Adenoidectomy | 13 515 (33.5) | 6048 (15.1) | 1604 (3.7) | 21 167 (17.1) |
| Appendectomya | — | 2285 (5.7) | 6143 (14.1) | 8565 (6.9) |
| Arthroscopic knee surgery | — | — | 11 816 (27.2) | 12 093 (9.7) |
| Cholecystectomy | — | — | 1165 (2.7) | 1239 (1.0) |
| Circumcision | 5747 (14.2) | 1450 (3.6) | 1249 (2.9) | 8446 (6.8) |
| Dental surgery | 6200 (15.4) | 5747 (14.4) | 10 320 (23.7) | 22 267 (17.9) |
| Orchiopexy | 1388 (3.4) | 1319 (3.3) | 1367 (3.1) | 4074 (3.3) |
| Tonsillectomy +/− adenoidectomy | 13 540 (33.5) | 23 098 (57.8) | 9823 (22.6) | 46 461 (37.4) |
| Common comorbidities,b n (%) | ||||
| OSA history | 7575 (18.8) | 8974 (22.5) | 2339 (5.4) | 18 891 (15.2) |
| Congenital defect diagnosis | 794 (2.0) | 590 (1.5) | 709 (1.6) | 2103 (1.7) |
| Cardiovascular diagnosis | 626 (1.5) | 492 (1.2) | 490 (1.1) | 1615 (1.3) |
| Neurologic/neuromuscular diagnosis | 428 (1.1) | 449 (1.1) | 385 (0.9) | 1262 (1.0) |
| Race or ethnicity, n (%) | ||||
| White, non-Hispanic | 24 950 (61.8) | 26 872 (67.3) | 30 348 (69.8) | 82 445 (66.4) |
| Black or African American | 2412 (6.0) | 2182 (5.5) | 2493 (5.7) | 7190 (5.7) |
| Asian, non-Hispanic | 1244 (3.1) | 1267 (3.2) | 1162 (2.7) | 3681 (3.0) |
| Hispanic/Latino | 3487 (8.6) | 4227 (10.6) | 4219 (9.7) | 11 989 (9.6) |
| Other/unknown | 8297 (20.5) | 5399 (13.5) | 5265 (12.1) | 19 025 (15.3) |
IQR, interquartile range; —, not applicable.
a
Procedures with <100 occurrences across 12 calendar months were not included in age brackets.
b
Comorbidities with 1% prevalence were not included.